Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **autonomic nervous system** is a major division of the peripheral nervous system responsible for regulating involuntary bodily functions such as heart rate, blood pressure, digestion, and respiratory rate. It consists primarily of two branches—the **sympathetic** and **parasympathetic** divisions—which often have opposing effects on target organs. The sympathetic division prepares the body for "fight-or-flight" responses by increasing cardiac output and redirecting blood flow to muscles. The parasympathetic division promotes "rest-and-digest" activities that conserve energy and facilitate maintenance functions[1][9]. At the molecular level, autonomic signaling occurs via neurotransmitters such as acetylcholine and norepinephrine acting on distinct classes of receptors—primarily **nicotinic**, **muscarinic**, **alpha-,** and **beta-adrenergic receptors**[1][5]. These individual receptor proteins are considered therapeutic targets in various diseases. For example: | Receptor Type | Molecular Classification | Example Drugs | |----------------------|---------------------------------|-------------------| | Nicotinic receptor | Ligand-gated ion channel | Varenicline | | Muscarinic receptor | G protein–coupled receptor | Atropine | | Alpha adrenergic | G protein–coupled receptor | Prazosin | | Beta adrenergic | G protein–coupled receptor | Atenolol | While modulation of overall autonomic tone can be achieved through interventions like renal denervation or baroreflex stimulation[2][3][6], these approaches ultimately act via altering activity at these underlying molecular targets. The term "autonomic nervous system" refers to an entire functional network rather than a discrete molecule or druggable target. Therefore it should not be classified as a canonical therapeutic target itself but rather as an anatomical/physiological entity composed of many individual druggable proteins. If you require structured information about specific molecular targets within the autonomic nervous system—such as muscarinic acetylcholine receptors or beta-adrenoceptors—please specify which one(s) you need detailed data for.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autonomic nervous system (ANS).